# Exsitec Reports Third Quarter Results for 2024
Exsitec, a leading provider of digital solutions, has reported a operating result of -1 million SEK for the third quarter of 2024, showing a decrease compared to the previous quarter.
## Financial Highlights
– Net sales reached 161 million SEK, a slight increase from the previous quarter.
– Organic growth was at -5%, with 3% attributed to project challenges in Norway.
– EBITA result was 5 million SEK, down from 9 million SEK.
– Adjusted EBITA margin decreased to 4%, from 8%.
# Kinnevik’s Third Quarter 2024 Results
Investment company Kinnevik disclosed a net asset value of 132 SEK per share at the end of the third quarter of 2024. However, total net asset value decreased by 5% compared to the previous quarter, despite a 14% decrease from the previous year after adjusting for an extra cash distribution of 6.4 billion SEK.
## Key Points
– Net income for the quarter was -1.913 million SEK, an improvement from the previous quarter.
– The company wrote down its valuation of portfolio company Village MD to zero due to uncertainties surrounding the controlling shareholder Walgreens.
– Substantial depreciation in the Village MD contributed to the decrease in Kinnevik’s net asset value.
# Flerie’s Financial Performance in Q3 2024
Flerie, focusing on biotechnology and pharmaceutical investments, reported a net income of -117 million SEK for the third quarter of 2024, showing an improvement from the previous year. The company’s net asset value increased to 54.59 SEK per share compared to 52.88 SEK a year ago.
## Notable Figures
– Total net asset value rose to 4.262 million SEK from 3.212 million SEK.
– The company showed a positive net income trend, indicating a stronger financial position.
# Vaxxa’s Growth in Q3 2024
Digital auction company Vaxxa recorded a net revenue of 21.3 million SEK for the third quarter of 2024, a significant increase compared to the previous year. The company also reported a positive EBITDA result, showcasing its operational efficiency and financial stability.
## Financial Indicators
– EBITDA result improved to 0.6 million SEK from -0.5 million SEK.
– Liquid assets increased to 7.6 million SEK from 4.4 million SEK.
# Stillfront’s Financial Expectations for Q3 2024
Stillfront, a game developer, anticipates a lower adjusted EBITDAC result than market expectations for the third quarter of 2024, primarily due to higher user acquisition costs. Despite this, the company projects a strong free cash flow of 298 million SEK.
## Forecasts
– Net revenue is expected to reach 1.595 billion SEK, down from 1.671 billion SEK in the previous year.
– Full financial report will be released on October 23, 2024.
# Emilshus Reports Strong Third Quarter Performance
Real estate company Emilshus disclosed impressive financial results for the third quarter of 2024, with an increase in rental income, operating surplus, and management results.
## Highlights
– Rental income reached 173 million SEK, up from 149 million SEK.
– Operating surplus and management results also showed significant improvements.
– Property value changes had a positive impact on the company’s financial performance.
## Analysis:
– Exsitec: While Exsitec’s decrease in operating result may raise concerns, the slight increase in net sales shows potential for growth. Understanding the factors contributing to the organic growth decline is essential to address challenges effectively and strategize for future success.
– Kinnevik: The write-down of Village MD’s valuation indicates a cautious approach to managing risks and preserving value. Despite the decrease in net asset value, Kinnevik’s decision could lead to long-term benefits by mitigating uncertainties.
– Flerie: Flerie’s improved financial performance suggests a positive outlook for the company, with higher net asset value and reduced net income losses. This trend indicates effective management strategies and potential growth opportunities in the biotechnology and pharmaceutical sectors.
– Vaxxa: Vaxxa’s significant revenue growth and positive EBITDA result reflect operational efficiency and financial stability. The company’s focus on digital solutions seems to resonate well with market demands, positioning Vaxxa for continued success.
– Stillfront: While Stillfront’s lower than expected adjusted EBITDAC result may raise concerns, the strong projected free cash flow indicates financial resilience. By strategically investing in user acquisition, Stillfront aims to drive long-term growth and profitability.
– Emilshus: Emilshus’ strong third-quarter performance, marked by increased rental income and property value changes, showcases the company’s effective management and growth potential in the real estate sector. By capitalizing on these strengths, Emilshus can further enhance its financial position and market competitiveness.